CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 41 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2014 | $178,000 | – | 19,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
Quilter Plc | 60,546 | $19,000 | 0.00% |
ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
BlackRock Inc. | 645,611 | $200,000 | 0.00% |
Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |